This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chinese Academy of Sciences, Nanovision Technology (Beijing) Co., Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024-2026
Title: Innovations by Qing Wei in Biofilm Inhibition
Introduction
Qing Wei is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of microbiology, particularly in the area of biofilm formation. His innovative approaches aim to enhance the effectiveness of antibiotics against bacterial infections.
Latest Patents
Qing Wei holds a patent for "Methods and compositions for inhibiting formation of biofilms." This patent discloses a method for inhibiting the formation of bacterial biofilms using a coumarin-chalcone compound. The method not only inhibits biofilm formation but also reduces the virulence of bacteria and enhances their susceptibility to antibiotics when used in combination. The composition described in the patent includes an effective amount of the coumarin-chalcone compound and may also incorporate an antibiotic, which can lower the minimal inhibitory concentration and minimal biofilm elimination concentration.
Career Highlights
Qing Wei is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions to combat bacterial infections. His work has garnered attention for its potential applications in medical and pharmaceutical fields.
Collaborations
Qing Wei collaborates with notable colleagues, including Luyan Ma and Pramod Bhasme, to further advance research in biofilm inhibition and related areas.
Conclusion
Qing Wei's contributions to the field of biofilm inhibition represent a significant advancement in microbiological research. His innovative methods and compositions have the potential to improve antibiotic efficacy and combat bacterial infections effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile